Overall, similar to the expression pattern in other tumors [8–10], these results indicate that the expression of UBE3C is significantly elevated in BrCa and that upregulation of UBE3C may play an critical role in BrCa progression. The gene discussed is UBE3C; the disease is invasive breast carcinoma.